Home » Medical Devices » Neurostimulation Devices Market

Neurostimulation Devices Market By Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Gastric Electric Stimulators), By Therapeutic Areas (Pain Management, Epilepsy, Essential Tremors, Urinary And Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease) – Growth, Future Prospects & Competitive Analysis, 2016 – 2024

Price: $4999

Published: | Report ID: 14447 | Report Format : PDF

Market Insights

Neurostimulation is the process of agitating or modulating neural activities for therapeutic purposes. Neurostimulation devices are used for neuromodulation and function by either stimulating nerve impulses or inhibiting pain signals at specific sites such as the autonomic nervous system, peripheral nervous system, deep brain nuclei, or central nervous system.

Significant growth in the geriatric population base has triggered the incidence of age-related nervous conditions such as Alzheimer’s disease and Parkinson’s disease and has thereby presented an area of high unmet medical needs in neurological disease segments. Similar scenarios are also experienced in other conditions, such as chronic pain, migraine, epilepsy, and others. Going forward, it is expected that the growth of the neurostimulation devices market will be facilitated by the efficient harnessing of the untapped market opportunities in the Asia-Pacific and Latin American markets, furthering the evolution of neurostimulation treatments.

This report attempts to study the global neurostimulation devices market in terms of product types, therapeutic areas, and regional distribution. Based on product types, this report studies the individual markets for a spinal cord stimulator, a deep brain stimulator, a sacral nerve stimulator, a vagus nerve stimulator, and a gastric electric stimulator.

Whereas, in terms of therapeutic areas, the report studies the global neurostimulation devices market for pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, Parkinson’s disease, and other therapeutic areas. Market size and forecasts for each mentioned segment are provided in this report for the period 2013–2024 (US$ Mn), along with respective CAGRs (value %) for the period2016–20244.

Geographically, the neurostimulation devices market is studied for the following regional markets:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

The market size and respective forecasts for these regional and country-level markets are presented in this study for the period 2013–2024. Market growth rates for the forecast period 2016–2024 are also included in this report, considering 2015 as the base year. This study also includes cross-sectional market size and forecast for each regional market, thus considering product types and therapeutic areas.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global neurostimulation devices market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive scenario of the global neurostimulation devices market. This report concludes with a company profiles section that highlights major information about the key players engaged in the development, manufacture, and sale of neurostimulation devices.

Based on the types of therapeutic areas where neurostimulation is significantly in demand, the global neurostimulation devices market is segmented as follows:

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and femoral incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Others

Pain management is the mainstay of neurostimulation applications; the highest prevalence of chronic pain, surgical pain, and trauma-related pain are the major therapeutic areas where neurostimulation devices are extensively used as adjuncts to conventional medication administration.

In addition, the market size of neurostimulation devices for treating Parkinson’s disease is expected to progress at an impressive rate due to the large geriatric patient pool and the proven efficiency of neurostimulation devices in treating neurological disorders. Other conditions, such as migraine and epilepsy, are observed to have high unmet needs in terms of efficient treatment. Such disparities in disease prevalence and treatment efficacy are essentially profitable market opportunities for the neurostimulation devices market.

Based on the product types, the global neurostimulation devices market is segmented as follows:

  • Stimulator of the Spinal Cord
  • deep brain stimulator
  • sacral nerve stimulator
  • Vagus Nerve Stimulator
  • gastric electric stimulator

Spinal cord stimulation currently dominates the overall market in terms of revenue share, and it is anticipated that the segment will retain its dominance through the forecast period. The popularity of spinal cord stimulators is largely due to their larger application and patient base, as well as their extensive market penetration.

The introduction of technologically advanced devices in this segment will further assist in market sustenance. Some of the recent technological advancements in this space are MRI-safe devices, tripolar leads, etc. However, there is a growing demand for sacral nerve stimulation devices and deep brain stimulators. Based on the same, it is anticipated that the revenue share of sacral nerve stimulators and deep brain stimulators will augment through the forecast period. In addition, the demand for gastric electric stimulators is also expected to grow further due to their expanding application areas, such as their promising role in obesity control.

For this study, the global market for neurostimulation devices is divided into the following groups:

  • North America (U.S., Canada)
  • Europe (U.K., Germany, rest of Europe)
  • Asia Pacific (Japan, China, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Saudi Arabia, South Africa, and the rest of the Middle East and Africa

North America accounted for the largest revenue share in the global neurostimulation devices market. However, the region is expected to lose its market share to rapid developments in European and Asia-Pacific markets and stringent regulatory policies in the U.S. and yet retain its dominance during the forecast period.

In addition, the presence of large unmet needs in Asia and Latin America will make the manufacturers shift their focus from North America and Western Europe and allow the fastest market growth rates in these regions. Improving disposable incomes among the general population and raising awareness about the availability of the latest treatments for neurodegenerative diseases are anticipated to be the chief environmental factors prevalent in the region. The presence of a sizable patient population base will also drive market growth in the Asia Pacific.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Neurostimulation Devices Market Portraiture
2.2 Global Neurostimulation Devices Market (US$ Mn), by Type, 2015
2.3 Global Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2015
2.4 Global Neurostimulation Devices Market Share (Value %), by Geography, 2015

Chapter 3 Global Neurostimulation Devices Market Overview
3.1 Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Market Competition Assessment: Neurostimulation Devices Market, by Key Players

Chapter 4 Global Neurostimulation Devices Market (US$ Mn), By Type, 2013-2024
4.1 Introduction
4.2 Spinal Cord Stimulators
4.3 Deep Brain Stimulators
4.4 Sacral Nerve Stimulators
4.5 Vagus Nerve Stimulators
4.6 Gastric Electric Stimulators

Chapter 5 Global Neurostimulation Devices Market (US$ Mn), By Therapeutic Areas, 2013-2024
5.1 Introduction
5.2 Pain Management
5.3 Epilepsy
5.4 Essential Tremors
5.5 Urinary and Fecal Incontinence
5.6 Depression
5.7 Dystonia
5.8 Gastroparesis
5.9 Parkinson’s Disease
5.10 Others

Chapter 6 Global Neurostimulation Devices Market (US$ Mn), By Geography, 2013-2024
6.1 Preface
6.2 North America (U.S., Canada)
6.3 Europe (U.K., Germany, Rest of Europe)
6.4 Asia Pacific (Japan, China, Rest of Asia Pacific)
6.5 Latin America (Brazil, Mexico, Rest of LATAM)
6.6 Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)

Chapter 7 Company Profiles
7.1 Medtronic
7.2 St. Jude Medical
7.3 Boston Scientific Corporation
7.4 Cyberonics
7.5 Nevro Corp
7.6 Cogentix Medical
7.7 Neuronetics, Inc.
7.8 IntraPace, Inc.
7.9 Codman & Shurtleff, Inc.
7.10 Other Notable Players

List of Figures

FIG. 1 Neurostimulation Devices Market: Research Methodology
FIG. 2 Global Neurostimulation Devices Market (US$ Mn), by Type, 2015
FIG. 3 Global Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2015
FIG. 4 Global Neurostimulation Devices Market (Value %), by Geography, 2015
FIG. 5 Attractive Investment Proposition, by Geography, 2015
FIG. 6 Market Positioning of Key Neurostimulation Devices Companies, 2015
FIG. 7 Global Spinal Cord Stimulators Market (US$ Mn), 2013–2024
FIG. 8 Global Deep Brain Stimulators Market (US$ Mn), 2013–2024
FIG. 9 Global Sacral Nerve Stimulators Market (US$ Mn), 2013–2024
FIG. 10 Global Vagus Nerve Stimulators Market (US$ Mn), 2013–2024
FIG. 11 Global Gastric Electric Stimulators Market (US$ Mn), 2013–2024
FIG. 12 Global Neurostimulation Devices Market in Pain Management (US$ Mn), 2013–2024
FIG. 13 Global Neurostimulation Devices Market in Epilepsy Treatment (US$ Mn), 2013–2024
FIG. 14 Global Neurostimulation Devices Market in Essential Tremors Management (US$ Mn), 2013–2024
FIG. 15 Global Neurostimulation Devices Market in Urinary and Fecal Incontinence Treatment (US$ Mn), 2013–2024
FIG. 16 Global Neurostimulation Devices Market in Depression Treatment (US$ Mn), 2013–2024
FIG. 17 Global Neurostimulation Devices Market in Dystonia Treatment (US$ Mn), 2013–2024
FIG. 18 Global Neurostimulation Devices Market in Gastroparesis Treatment (US$ Mn), 2013–2024
FIG. 19 Global Neurostimulation Devices Market in Parkinson’s Disease Treatment (US$ Mn), 2013–2024
FIG. 20 Global Neurostimulation Devices Market in Other Therapeutic Areas (US$ Mn), 2013–2024

List of Tables

TABLE 1 Global Neurostimulation Devices Market (US$ Mn), By Type, 2013-2024
TABLE 2 Global Neurostimulation Devices Market (US$ Mn), By Therapeutic Areas, 2013-2024
TABLE 3 Global Neurostimulation Devices Market (US$ Mn), by Geography, 2013–2024
TABLE 4 North America Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 5 North America Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 6 North America Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 7 Europe Neurostimulation Devices Market, by Country, 2013–2024 (US$ Mn)
TABLE 8 Europe Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 9 Europe Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 10 Europe Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 11 Asia Pacific Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 12 Asia Pacific Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 13 Latin America Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 14 Latin America Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 15 Latin America Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 16 Middle East and Africa Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 17 Middle East and Africa Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 18 Middle East and Africa Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 19 Medtronic: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 20 St. Jude Medical: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 21 Boston Scientific Corporation: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 22 Cyberonics: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 23 Nevro Corp: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 24 Cogentix Medical: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 25 Neuronetics, Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 26 IntraPace, Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 27 Codman & Shurtleff, Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)

Frequently Asked Questions:

What is the size of Neurostimulation Devices Market?

The market for Neurostimulation Devices Market is expected to reach US$ 17,017.1 Mn By 2024.

What is the Neurostimulation Devices Market CAGR?

The Neurostimulation Devices Market is expected to see significant CAGR growth over the coming years, at 13.0%.

What is the Forecast period considered for Neurostimulation Devices Market?

The report is forecasted from 2016-2024.

What is the base year considered for Neurostimulation Devices Market?

The base year of this report is 2015.

Who are the major players in this market?

St.Jude Medica, Boston Scientific Corporation, Codman & Shurtleff, Inc., Neuronetics, Inc. are some of the major players in the global market.

Manual Resuscitators Market

Published:
Report ID: 38693

Orthopedic Splints and Casts Market

Published:
Report ID: 18021

Vietnam Medical Laser Market

Published:
Report ID: 38377

Atrial Fibrillation Devices Market

Published:
Report ID: 2420

Atherectomy Devices Market

Published:
Report ID: 2391

US Pharmacy Automation Market

Published:
Report ID: 38274

Veterinary Hematology Analyzers Market

Published:
Report ID: 11808

Franz Cell and Vapometer Market

Published:
Report ID: 37491

Europe Elderly Care Services Market

Published:
Report ID: 37291

Blood and Fluid Warming Systems Market

Published:
Report ID: 2312

India Wound Care Market

Published:
Report ID: 37156

Negative Pressure Wound Therapy Market

Published:
Report ID: 14408

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN